Plasma LPS is a marker of metabolic syndrome. The Plasma sCD14 and iFABP are not elevated across the histological subgroups of NAFLD. The plasma TLR receptors were high among the obese population, but cytokine and chemokines were significantly high in liver inflammation. Here, FABP2 is linked to metabolic dysfunction-associated steatotic liver disease.